Introduction {#sec1}
============

Gastric tumor remains one of the most common and heterogeneous neoplasms in the world. Neoplasms pose an important diagnostic and therapeutic challenge in contemporary clinical gastroenterology. They also remain among the top ten major cancer diseases worldwide \[[@B1],[@B2]\]. In China, gastric cancer (GC) is among the top three causes of incidence rates and mortality \[[@B3]\], and the 5-year survival rate of GC is low \[[@B1],[@B4]\]. GC is treated with surgery, radiochemotherapy, immunotherapy and targeted approaches with anti-angiogenic monoclonal antibodies and tyrosine kinase inhibitors, if tumors harbor a specific mutation. Although surgery, chemotherapy, radiotherapy and molecularly targeted drug therapy have provided a means for GC treatment, the prognosis of patients with GC is still not optimistic, and the 5-year overall survival (OS) rate remains low. Biotherapy has achieved certain effects on GC defined by immune cells recruited to and activated in a tumor microenvironment (TME) \[[@B5]\], but the role of immune cells in a TME remains poorly understood.

Tumor inflammatory response has played an important role in cancer occurrence and progression. Several studies have shown that tumor-infiltrating immune cells (TIICs) can help hosts resist cancer cells and promote solid tumor development \[[@B6]\]. As immuno-sensitive tumors, numerous TIICs including T and B lymphocytes and neutrophils are present in the tumor stroma. Cell density and type are closely related to the clinical outcomes of tumors \[[@B7]\]. In previous studies, TIICs have been examined by immunohistochemical methods which rely on a single marker to identify a specific TIIC subgroup \[[@B10]\]. As such, these approaches are not comprehensive and can be misleading. When few cells are detected or closely related to the cell type, immunohistochemical effect is poor. Consequently, few studies have elucidated the prognostic value of these TIIC subgroups.

Cell type Identification By Estimating Relative Subsets Of known RNA Transcripts (CIBERSORT) \[[@B13]\] has been developed as a new system biology tool which can identify 22 types of immune cells based on transcriptome data. In this research, the gene expression data of 407 patients were collected from The Cancer Genome Atlas (TCGA), and 22 TIIC subsets of GC immune cells were quantified using CIBERSORT for the first time. The relationship between immune cells and clinical features was also explored. Our findings revealed the immunogenomic phenotypes of GC subclasses and provided novel insights into GC immunotherapy and the relationship of complex GC progression, tumor molecular subtypes and immune cell heterogeneity.

Methods {#sec2}
=======

Gene expression datasets {#sec2-1}
------------------------

The GC dataset including basic information, gene expression profiles and corresponding prognosis information was downloaded from the publicly available dataset of TCGA \[[@B14]\]. Only patients with confirmed GC and clinicopathological and survival information were included in the study. Patients with insufficient or missing datasets such as age, TNM stage and OS, were excluded in the subsequent treatment. RNA sequencing data were converted using the voom (variance modeling at the observational level) method \[[@B15],[@B16]\] and counted data were transformed to values closer to microarray results.

TIIC quantification via the CIBERSOFT algorithm {#sec2-2}
-----------------------------------------------

The CIBERSORT algorithm was used to determine the immune-related signature from 547 marker immune genes and quantify the relative fraction of each immune cell type. The method was employed to infer their relative proportions of 22 immune cells. Gene expression datasets were written by using standard annotation files, and data were uploaded to the CIBERSORT web and run by using the default signature matrix with 1000 kinds of arrangement. With the CIBERSORT algorithm, *P*-values were obtained for each deconvolution sample via Monte Carlo sampling, which could make each result credible.

The total number of T cells was estimated as the sum of the fraction of CD8^+^ T cells, CD4^+^ naïve T cells, CD4^+^ memory resting T cells, activated CD4^+^ memory T cells, follicular helper T cells, regulatory T cells (Tregs) and γδ T cells. The total macrophage fraction was calculated as the sum of the fractions of M0, M1 and M2 macrophages. The total number of B cells was determined as the sum of memory and naïve B cells.

Survival analysis {#sec2-3}
-----------------

Twenty-two human immune cell phenotypes were further screened. Univariate Cox analysis and Kaplan--Meier survival analysis were performed on LM22 and overall survival (OS) by using the 'survfit' function of the survival package in R software. The relationship between clinical feature (TNM stage, radiotherapy, grade) and LM22 was also explored.

Identification of molecular subtypes {#sec2-4}
------------------------------------

A consensus clustering algorithm was applied to determine the number of clusters and further explore different patterns of TIICs by using the 'CancerSubtypes' R-package \[[@B17]\]. Differentially expressed genes (DEGs) and different immune cell types were determined with the Limma R-package to explore the differences in TIICs among each cluster. When DEGs in the dataset were expressed with \|log2 fold-change\| ≥ 0.1 and adjusted *P*\<0.05 was set as the selection standard for subsequent analysis.

Functional and pathway enrichment analysis {#sec2-5}
------------------------------------------

Gene Ontology (GO) \[[@B18]\] and Kyoto Encyclopedia of Genes and Genomes (KEGG) (<http://www.genome.ad.jp/kegg/>) \[[@B19]\] are the most commonly used tools to describe molecular biology information, such as gene functions, biological functions, protein networks and genomic information. 'ClusterProfiler' R package was used to conduct functional and pathway enrichment analysis and reveal the potential biological significance of DEGs among each subtype with a cut-off point of \|log2 fold-change\| ≥ 0.2 and *P*\<0.05. Then, gene set variation analysis (GSVA) revealed the overall pathway of the gene set pathway scores of each sample. Gene sets with c2-curated signatures were downloaded from the Molecular Signature Database of Broad Institute. The obvious enrichment pathway was determined with a threshold of \|log fold-change\| ≥ 0.2 and adjusted *P*\<0.05.

Statistical analyses {#sec2-6}
--------------------

Samples with *P*\<0.05 calculated with CIBERSORT were included in the analysis. After they were initially screened, eligible samples were divided into two groups: paired tumor group and paired adjacent tissue group. Pearson correlation analysis was performed with the R software to explore the mutual relationship among three clusters. A Wilcoxon test was conducted to examine the statistical significance between the two groups. A Kruskal--Wallis test was performed to compare the differences between the two groups. A log-rank test was carried out and Kaplan--Meier curves were obtained to examine the differences in OS between the groups.

In the univariate Cox regression analysis, variables with *P*\<0.05 were considered as independent prognostic factors, and prognostic LM22 immune cells were further analyzed through multivariate COX regression analysis. The area under the curve (AUC) and the confidence interval under ROC curves were calculated using the R package 'pROC' which was used to evaluate the diagnostic accuracy of prognostic LM22 immune cells. Statistical analysis was conducted using software packages provided by the R-Language ([R-project.org](http://R-project.org)) and Bioconductor project ([www.bioconductor.org](http://www.bioconductor.org)).

All analyses were performed using R version 3.3.0. All *P*-values were two-sided, and any *P*\<0.05 was considered statistically significant.

Results {#sec3}
=======

Overview of data {#sec3-1}
----------------

The flowchart of study design and the analysis process is exhibited in [Figure 1](#F1){ref-type="fig"}. A total of 407 samples including 32 adjacent-tumor samples and 375 tumor samples were obtained from the TCGA. After the CIBERSOFT algorithm was used, the sample with *P*\<0.05 including 15 paracancerous tissues and 244 tumor tissues were considered in the main research contents. After the samples were matched, 22 cases of paired adjacent tumor tissues and paired tumor tissues were selected. The expression profiles of 547 TME-related genes were extracted for further analysis.

![Flowchart detailing the study design and samples at each stage of analysis](bsr-40-bsr20193308-g1){#F1}

Overview of immune infiltration in GC {#sec3-2}
-------------------------------------

The difference between paired cancer and adjacent tissues in 22 immune cells was analyzed by using the CIBERSORT algorithm. [Figure 2](#F2){ref-type="fig"} summarizes the results obtained from 22 pairs of the matched patients. Obviously, the proportion of immune cells in GC tumor tissues was significantly different from that in normal tissues. Therefore, changes in TIICs proportions might be intrinsic to individual differences. In [Figure 3](#F3){ref-type="fig"}, the fractions of total T cells, total macrophages and total B cells were higher in GC tumor tissues than in adjacent tumor tissues. Plasma cells, resting CD4 memory T cells, activated CD4 memory T cells, M0 macrophages and M1 macrophages significantly changed between adjacent tumor and tumor groups. The fractions of activated CD4 memory T cells, Tregs, M0 macrophages, M1 macrophages and neutrophils were higher in the tumor samples than in the adjacent tumor samples. The fractions of plasma cells and resting CD4 memory T cells were higher in the adjacent samples than in the tumor samples ([Figure 4](#F4){ref-type="fig"}, [Table 1](#T1){ref-type="table"}).

![The performance of CIBERSOST for estimating TIICs composition in GC\
(**A**) Relative proportions of 22 TIICs subpopulation in normal samples. (**B**) Relative proportions of 22 TIICs subpopulation in tumor samples. (**C**) Heatmap of the 22 immune cells' proportions.](bsr-40-bsr20193308-g2){#F2}

![The distribution of 22 immune cell infilteration between GC adjacent tissues and tumor tissues\
The stacked histogram shows the distribution of 22 immune cell infiltration between GC adjacent tissues and tumor tissues, including total immune cells (**A**), total T cells (**B**), total B cells (**C**) and total macrophages (**D**).](bsr-40-bsr20193308-g3){#F3}

![The violin plot exhibits the difference between CIBERSORT immune cell fractions between GC adjacent tissues and tumor tissues](bsr-40-bsr20193308-g4){#F4}

###### Comparison of CIBERSORT immune cell fractions between normal tissues and tumor tissues in GC

  Immune cell type               CIBERSORT fraction in % of all infiltrating immune cells                   
  ------------------------------ ---------------------------------------------------------- ------- ------- --------
  Naive B cells                  0.237                                                      0.033   0.055   0.742
  Memory B cells                 0.634                                                      0.027   0.018   −0.590
  Plasma cells                   \<0.001                                                    0.297   0.052   −2.523
  CD8 T cells                    0.562                                                      0.146   0.172   0.230
  Naive CD4 T cells              NA                                                         NA      NA      NA
  Resting CD4 memory T cells     0.047                                                      0.185   0.114   −0.700
  Activated CD4 memory T cells   0.033                                                      0.009   0.053   2.484
  Follicular helper T cells      0.100                                                      0.021   0.036   0.814
  Tregs                          0.019                                                      0.047   0.075   0.674
  γδ T cells                     1                                                          0.003   0.002   −0.153
  Resting NK cells               0.089                                                      0.005   0.020   1.896
  Activated NK cells             0.426                                                      0.016   0.012   −0.393
  Monocytes                      0.205                                                      0.014   0.008   −0.769
  M0 macrophages                 \<0.001                                                    0.012   0.133   3.472
  M1 macrophages                 0.001                                                      0.022   0.074   1.769
  M2 macrophages                 0.116                                                      0.065   0.085   0.387
  Resting dendritic cells        1                                                          0.019   0.022   0.200
  Activated dendritic cells      0.528                                                      0.008   0.014   0.793
  Resting mast cells             0.509                                                      0.040   0.026   −0.596
  Activated mast cells           0.390                                                      0.013   0.017   0.327
  Eosinophils                    0.591                                                      0.005   0.004   −0.308

NA: not available.

The proportions of different TIICs were moderately to strongly correlated in the GC-paired adjacent tumor samples. The mutual relationship in LM22 immune cells reduced in the tumor samples. For examples, follicular helper T cells were highly and positively associated with memory B cells in the immune phenotype profiles in the TMC from the GC-paired adjacent tumor samples, whereas CD8 T cells were highly and negatively related to resting CD4 memory T cells in the GC-paired adjacent tumor group (Supplementary Figure S1). Therefore, we hypothesized that alterations in the TME cell infiltration rate directly reflected differences in immunity between the two groups.

In terms of clinical features, several LM22 immune cells were associated with clinical characteristics ([Figure 5](#F5){ref-type="fig"}). Pathological stage was associated with M1 macrophages and eosinophils. As the TNM stage increased, the degree of M1 macrophages also enhanced except for Stage IV. The eosinophils were mainly enriched in the Stage IV (Supplementary Figure S2A,B). Follicular helper T cells were activated at the late stage (G3/G4) (Supplementary Figure S2C). Monocytes were associated with radiation therapy. The fraction of total B cells was higher in the samples without radiation therapy than in the samples with radiation therapy, whereas the fraction of total macrophages was higher in the latter than in the former (Supplementary Figure S3, [Table 2](#T2){ref-type="table"}).

![Clinical characteristics of several LM22 immune cells in GC](bsr-40-bsr20193308-g5){#F5}

###### Comparison of immune cell fractions between with radiation and without radiation in GC

  Immune cell type               The fraction in % of all infiltrating immune cells                   
  ------------------------------ ---------------------------------------------------- ------- ------- --------
  Naive B cells                  0.060                                                0.052   0.073   0.494
  Memory B cells                 0.674                                                0.026   0.036   0.441
  Plasma cells                   0.229                                                0.055   0.042   −0.403
  CD8 T cells                    0.590                                                0.123   0.120   −0.044
  Naive CD4 T cells              0.623                                                0.001   0.000   NA
  Resting CD4 memory T cells     0.155                                                0.166   0.192   0.209
  Activated CD4 memory T cells   0.486                                                0.046   0.032   −0.545
  Follicular helper T cells      0.229                                                0.029   0.023   −0.352
  Tregs                          0.847                                                0.063   0.060   −0.062
  γδ T cells                     0.417                                                0.001   0.002   1.159
  Resting NK cells               0.505                                                0.012   0.014   0.220
  Activated NK cells             0.697                                                0.022   0.018   −0.300
  Monocytes                      0.005                                                0.003   0.009   1.759
  M0 macrophages                 0.978                                                0.126   0.118   −0.101
  M1 macrophages                 0.568                                                0.071   0.063   −0.183
  M2 macrophages                 0.601                                                0.097   0.093   −0.065
  Resting dendritic cells        0.447                                                0.018   0.020   0.132
  Activated dendritic cells      0.152                                                0.019   0.009   −1.116
  Resting mast cells             0.579                                                0.032   0.036   0.153
  Activated mast cells           0.796                                                0.025   0.024   −0.078
  Eosinophils                    0.918                                                0.002   0.001   −0.624
  Neutrophils                    0.770                                                0.009   0.017   0.891

Identification of prognostic LM22 immune cell subtypes {#sec3-3}
------------------------------------------------------

Univariate Cox regression was performed to identify the prognostic LM22 immune cell subsets in all the tumor samples, and the results showed that two immune cell subsets (γδ T cells and neutrophils) were significantly correlated with OS (*P*\<0.05) ([Figure 6](#F6){ref-type="fig"}A, [Table 3](#T3){ref-type="table"}). In multivariate Cox regression, activated CD4 memory T cells, resting mast cells and CD8 T cells were significantly correlated with OS ([Figure 6](#F6){ref-type="fig"}B, [Table 3](#T3){ref-type="table"}).

![The prognostic associations of subsets of immune cells in univariate Cox regresion and multivariate Cox regression\
**A**) Univariate Cox regression and (**B**) Multivariate Cox regression.](bsr-40-bsr20193308-g6){#F6}

###### The prognostic associations of subsets of immune cells in univariate and multivariate Cox regression

  The prognostic associations of subsets of immune cells in univariate Cox regression                                          
  ------------------------------------------------------------------------------------- ---------- -------- ------- ---------- ----------
  γδ T cells                                                                            43477699   2.226    0.026   8.154      2.32E+14
  Neutrophils                                                                           526.096    2.059    0.039   1.352      204721
  Resting CD4 memory T cells                                                            11.844     1.955    0.051   0.994      141.090
  CD8 T cells                                                                           0.079      −1.890   0.059   0.006      1.099
  Activated CD4 memory T cells                                                          0.017      −1.794   0.073   0.000      1.456
  Monocytes                                                                             600712\.   1.519    0.129   0.021      1.72E+13
  Naive B cells                                                                         13.344     1.306    0.191   0.274      650.914
  Naive CD4 T cells                                                                     30726951   0.978    0.328   3.03E-08   3.12E+22
  M2 macrophages                                                                        4.998      0.928    0.353   0.167      149.236
  Tregs                                                                                 0.113      −0.753   0.452   0.000      33.128
  M0 macrophages                                                                        0.521      −0.615   0.539   0.065      4.165
  Activated dendritic cells                                                             0.117      −0.431   0.666   6.67E-06   2040\.
  Activated NK cells                                                                    7.244      0.426    0.670   0.001      65314
  Activated mast cells                                                                  2.434      0.424    0.671   0.040      148.105
  M1 macrophages                                                                        0.346      −0.409   0.683   0.002      56.079
  Follicular helper T cells                                                             0.129      −0.409   0.683   6.84E-06   2416
  Resting dendritic cells                                                               3.075      0.248    0.804   4.30E-04   22001
  Resting NK cells                                                                      0.303      −0.220   0.826   7.37E-06   12490
  Plasma cells                                                                          0.770      −0.172   0.863   0.039      15.235
  Eosinophils                                                                           0.330      −0.120   0.905   4.43E-09   24566051
  Resting mast cells                                                                    1.269      0.080    0.936   0.004      432.197
  Memory B cells                                                                        1.007      0.003    0.997   0.015      65.694

  The prognostic associations of subsets of immune cells in multivariate Cox regression                                                 
  --------------------------------------------------------------------------------------- --------- ---------- ----------- ------------ -------
  Naive B cells                                                                           −5.733    0.003      2.15E-07    48.874       0.243
  Memory B cells                                                                          −7.924    0.000      1.33E-08    9.875        0.128
  Plasma cells                                                                            −7.491    0.001      3.82E-08    8.152        0.126
  CD8 T cells                                                                             −9.032    0.000      1.82E-08    0.787        0.044
  Naive CD4 T cells                                                                       10.776    47852      5.68E-13    4.03E+21     0.588
  Resting CD4 memory T cells                                                              −6.388    0.002      2.09E-07    13.506       0.164
  Activated CD4 memory T cells                                                            −12.797   0.000      3.58E-11    0.214        0.026
  Follicular helper T cells                                                               −2.673    0.069      4.34E-08    109916.931   0.714
  Tregs                                                                                   −9.872    0.000      2.34E-10    11.350       0.116
  γδ T cells                                                                              17.979    64306589   0.043       9.73E+16     0.095
  Resting NK cells                                                                        −8.258    0.000      2.81E-12    23880        0.377
  Activated NK cells                                                                      −2.187    0.112      5.39E-08    233695       0.768
  Monocytes                                                                               −2.879    0.056      2.77E-13    1.14E+10     0.828
  M0 macrophages                                                                          −8.731    0.000      1.69E-08    1.543        0.062
  M1 macrophages                                                                          −5.998    0.002      4.391E-08   140.539      0.283
  M2 macrophages                                                                          −6.357    0.002      9.36E-08    32.178       0.205
  Resting dendritic cells                                                                 −5.789    0.003      3.48E-09    2695         0.407
  Activated dendritic cells                                                               −7.651    0.000      1.16E-10    1948         0.325
  Resting mast cells                                                                      −12.238   0.000      3.99E-11    0.588        0.040
  Activated mast cells                                                                    −9.893    0.000      6.94E-11    36.799       0.151
  Eosinophils                                                                             −15.905   0.000      5.24E-18    2923         0.192
  Neutrophils                                                                             NA        NA         NA          NA           NA

The ROC curves were used to evaluate the prognostic power of prognostic LM22 immune cell subsets. The AUC of prognostic LM22 immune cell subset biomarker model is shown in Supplementary Figure S4. In GC, resting mast cells, naïve B cells, monocytes, neutrophils, activated CD4 memory T cellsnd follicular helper T cells had an AUC of more than 0.550. Monocytes had the highest performance in the risk prediction of patients with GC.

Immune cell infiltration patterns in molecular GC subtypes {#sec3-4}
----------------------------------------------------------

The molecular classification of GC was identified by performing an unsupervised consensus clustering of 221 tumor samples to explore the infiltration of different immune cell populations in a TME in GC. The optimal number of clusters was determined with *K*. After the relative altercations in the area under the cumulative distribution function (CDF) curve and the consensus heatmap were evaluated, a three-cluster solution (*K* = 3) was selected, but it did not remarkably increase in the area under the CDF curve (Supplementary Figure S5). This finding classified 48 patients (21%) in cluster I, 103 patients (45%) in cluster II and 78 patients (34%) in cluster III for the GC cohort. The consensus matrix heatmap revealed cluster I, II and III with individualized clusters. The sample of each cluster is shown in [Figure 7](#F7){ref-type="fig"}. The clusters were associated with distinct survival patterns. The patients classified under cluster II had a good prognosis compared with those in clusters I and III.

![The cancer subtypes using SNFCC+ algorithm\
(**A**) Log-rank test *P*-value for Kaplan--Meier survival analysis. (**B**) Clustering heatmap visualizing the degree of the partitioning of the sample clusters. (**C**) Average silhouette width representing the coherence of clusters.](bsr-40-bsr20193308-g7){#F7}

Differentially expressed analysis of genes/LM22 immune cell fractions in each GC subgroup {#sec3-5}
-----------------------------------------------------------------------------------------

The Kruskal--Wallis test was conducted to identify the quantitative genes/LM22 immune cells significantly associated with each subclass. For differential LM22 immune cell in GC, cluster I was defined with a high level of eosinophils, M0 macrophages, activated mast cells, neutrophils and resting NK cells. Cluster II was enriched with naïve B cells, resting mast cells, monocytes, resting CD4 memory T cells, Tregs and activated NK cells. Cluster III was defined with a high level of activated CD4 memory T cells, CD8 T cells, follicular helper T cells and M1 macrophages ([Figure 8](#F8){ref-type="fig"}). The heatmap is also illustrated in Supplementary Figure S6.

![Box plot depicting the association between immune cell subsets and three clusters, depicted *P*-values are from the Kruskal--Wallis tests\
(**A**--**O**) are for eosinophils, M0 macrophages, activated mast cells, neutrophils, resting NK cells, naïve B cells, resting mast cells, monocytes, resting CD4 memory T cells, Tregs, activated NK cells, activated CD4 memory T cells, CD8 T cells, follicular helper T cells and M1 macrophages, respectively.](bsr-40-bsr20193308-g8){#F8}

An unpaired Student's *t* test was conducted to identify the quantitative genes significantly associated with each subtype and examine the molecular differences between GC molecular subtypes and derived subtype-specific biomarkers. The unmatched subgroups were subjected to DEG analysis with a threshold of absolute log-fold change cut-off \>0.1 and false discovery rate (FDR) = 0.05. [Figure 9](#F9){ref-type="fig"} shows DEGs in concentric circles radiating among the three clusters. A total of 158 mRNAs (192 up-regulated and 77 down-regulated genes) in subgroup I were differentially expressed compared with those in subgroups Ⅱ. In subgroup I compared with subgroups III, 216 differentially expressed mRNAs (28 up-regulated and 187 down-regulated genes) were detected. In subgroup Ⅱ compared with subgroup III, 313 differentially expressed mRNAs (26 up-regulated and 287 down-regulated genes) were observed.

![DEGs in concentric circles radiating among three GC subgroups\
(**A**--**C**) are for subgroup I vs subgroups II, subgroup 1 vs subgroups III, subgroup II vs subgroups III.](bsr-40-bsr20193308-g9){#F9}

GO, KEGG and GSVA of DEGs for molecular subtypes identification {#sec3-6}
---------------------------------------------------------------

A total of 639 GO terms of biological processes, 17 GO terms of cellular components and 54 GO terms of molecular functions in subgroup I were significantly compared with those in subgroup Ⅱ (adjusted *P*\<0.05). In subgroup I compared with subgroup III, 526 GO terms of biological processes, 31 GO terms of cellular components and 37 GO terms of molecular functions were significant. In subgroup Ⅱ compared with subgroup III, 605 GO terms of biological processes, 14 GO terms of cellular components and 31 GO terms of molecular functions were significant. The top GO terms included cytokine activity, immune/inflammatory response and chemokine activity. All the pathways obtained through KEGG analysis were associated with immune responses ([Figure 10](#F10){ref-type="fig"}). The unpaired Student's *t* test was conducted to identify quantitative genes and examine the molecular differences between GC subtypes and derived subtype-specific biomarkers.

![The GO and KEGG analysis for three GC clusters\
(**A,B**) Are for cluster I vs cluster II, (**C,D**) are for cluster I vs cluster III and (**E,F**) are for cluster II vs cluster III.](bsr-40-bsr20193308-g10){#F10}

Three clusters were subjected to GSVA by using the GSVA package of R software. The number of enriched pathways progressively increased from subtype I to subtype III. The most significantly enriched gene sets were ordered on the basis of significance (*P* and adjusted *P*-values of FDR) and listed in [Table 4](#T4){ref-type="table"}. In [Figure 11](#F11){ref-type="fig"}, several hallmark gene sets, including estrogen response late, apical junction, epithelial--mesenchymal transition (EMT), KRAS signaling and angiogenesis were observed.

![The GSVA analysis for three GC clusters](bsr-40-bsr20193308-g11){#F11}

###### The GSVA analysis for three GC clusters

                                               logFC    AveExpr   *t*      *P*-value   adj. *P*-value   B
  -------------------------------------------- -------- --------- -------- ----------- ---------------- --------
  HALLMARK_ESTROGEN_RESPONSE_LATE              0.421    −0.008    2.661    0.010       0.232            −2.710
  HALLMARK_XENOBIOTIC_METABOLISM               −0.378   0.019     −2.452   0.017       0.232            −3.093
  HALLMARK_HEME_METABOLISM                     −0.228   −0.004    −2.169   0.034       0.307            −3.573
  HALLMARK_ANGIOGENESIS                        −0.234   0.043     −1.595   0.116       0.696            −4.392
  HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION   −0.231   0.032     −1.470   0.147       0.696            −4.541
  HALLMARK_PEROXISOME                          −0.211   0.018     −1.394   0.169       0.696            −4.626
  HALLMARK_FATTY_ACID_METABOLISM               −0.221   0.008     −1.348   0.183       0.696            −4.676
  HALLMARK_APICAL_JUNCTION                     0.161    −0.022    1.153    0.253       0.696            −4.868
  HALLMARK_UV_RESPONSE_DN                      −0.191   0.022     −1.123   0.266       0.696            −4.895
  HALLMARK_SPERMATOGENESIS                     0.132    0.001     1.072    0.288       0.696            −4.939
  HALLMARK_KRAS_SIGNALING_DN                   −0.102   0.020     −1.046   0.300       0.696            −4.961
  HALLMARK_P53_PATHWAY                         0.141    −0.020    0.985    0.329       0.696            −5.011
  HALLMARK_IL2_STAT5_SIGNALING                 −0.101   0.013     −0.966   0.338       0.696            −5.026
  HALLMARK_MYOGENESIS                          0.158    −0.005    0.899    0.372       0.696            −5.076
  HALLMARK_INTERFERON_GAMMA_RESPONSE           0.104    −0.019    0.848    0.400       0.696            −5.111
  HALLMARK_ANDROGEN_RESPONSE                   0.116    −0.018    0.825    0.412       0.696            −5.126
  HALLMARK_NOTCH_SIGNALING                     0.108    −0.021    0.661    0.511       0.788            −5.225
  HALLMARK_ESTROGEN_RESPONSE_EARLY             0.113    0.029     0.639    0.525       0.788            −5.236
  HALLMARK_COMPLEMENT                          0.052    0.005     0.505    0.615       0.813            −5.298
  HALLMARK_INFLAMMATORY_RESPONSE               0.031    −0.007    0.370    0.713       0.813            −5.346
  HALLMARK_TNFA_SIGNALING_VIA_NFKB             −0.042   −0.031    −0.362   0.718       0.813            −5.349
  HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY     0.050    −0.003    0.360    0.720       0.813            −5.349
  HALLMARK_KRAS_SIGNALING_UP                   −0.039   0.014     −0.356   0.723       0.813            −5.350
  HALLMARK_WNT_BETA_CATENIN_SIGNALING          0.055    −0.016    0.325    0.746       0.813            −5.359
  HALLMARK_APICAL_SURFACE                      −0.047   0.003     −0.317   0.752       0.813            −5.361
  HALLMARK_GLYCOLYSIS                          0.043    −0.019    0.263    0.794       0.824            −5.374
  HALLMARK_ALLOGRAFT_REJECTION                 0.008    0.002     0.066    0.947       0.947            −5.400

Discussion {#sec4}
==========

The majority of patients with GC have been actively treated using a multimodality strategy \[[@B20]\], but their 5-year survival rates have not increased \[[@B21]\]. Although new immunotherapies have provided a new basis for treating patients with GC, their potential mechanism is still unclear, and further studies should be performed to develop the corresponding targeted therapy. Immune cells, which have multiple types and different functions, are the main TME components and major host cells recruited and activated by a TME. The immune system can promote and inhibit tumor growth, so this system is important for prognosis. Studies have suggested that TIICs have great potential for application in clinical outcome and therapeutic response prediction among individual patients. Jiang et al. \[[@B22]\] found that the density and distribution of TIICs may be useful in predicting the survival of patients with GC. Previous studies revealed that TIICs, such as mature T cells, dendritic cells and memory T cells with increased infiltration, are associated with good prognosis, whereas immunosuppressive Tregs are opposite \[[@B23],[@B24]\]. Previous studies also applied immunohistochemical methods to evaluate TIICs and identify the TIIC subgroup with a single surface marker because of technical limitations. However, these methods are poorly effective in identifying closely related cell types. As such, inconsistent results have been presented in clinical studies.

A combination of CIBERSOFT algorithms can overcome the shortcomings of traditional immunohistochemical methods and accurately address the relative proportions of different TIICs \[[@B12],[@B25]\]. Therefore, in the current study, CIBERSORT was used to infer the proportion of 22 immune cell subsets from the GC transcriptome. To our knowledge, this study was the first to comprehensively analyze the clinical effect of immune responses on GC.

In our study, the CIBERSOFT method was conducted to evaluate the infiltration of different immune cells in paired GC and adjacent normal tissues, and the results showed that the scores of immune cells significantly differed within and between groups. Our work also revealed the details of the infiltration of various subsets of LM22 immune cells in GC. The profiles of immune infiltration in the TCGA GC cohort varied significantly between 22 paired GC tissues. Plasma cells and resting CD4 memory T cells increased in the paired paracancerous tissues, whereas activated CD4 memory T cells and M0 macrophages decreased in the GC samples. In terms of clinical characteristics, the correlation between 22 immune cell subtypes and clinical characteristics was also analyzed. M1 macrophages and eosinophils were related to TNM stage. Follicular helper T cells were activated at the late stage (G3/G4), and monocytes were associated with radiotherapy. Among LM22 immune cells, Tregs were significantly associated with the OS of patients with GC. Therefore, these results demonstrated that aberrant immune infiltration and heterogeneity in GC as a tightly regulated process might play important roles in tumor development and this process had clinical importance.

Recent studies have found that the interaction of cytokines showed an important role in the development and progression of malignant tumors. Previous studies have revealed that IL-17 was involved in tumor occurrence, metastasis, angiogenesis, immune-resistance and other processes \[[@B26]\], and confirmed that IL-17 signaling pathway also played an important role in the occurrence and progression of GC \[[@B29]\], breast cancer \[[@B30]\] and pancreatic cancer \[[@B31]\]. Meanwhile, Liu et al. \[[@B32]\] obtained the data of *Helicobacter pylori* GC samples from TCGA and revealed that cytokine--cytokine receptor interaction was enriched in *H. pylori* (+) GC through GO and KEGG analysis. Wu et al. \[[@B33]\] used Human gene chip Affymetrix HTA 2.0, obtained 1312 DEGs in GES-1 cell lines with *H. pylori* and TMAO co-treatment compared with the control, and Toll-like receptor signaling pathway was showed to be the most important biological processes. Yu et al. \[[@B34]\] used multimarker analysis of genomic annotation to analyze pathways, and identified that chemokine signaling pathway was associated with GC risk. In our study, DEGs were conducted through GO and KEGG analysis. The top GO terms included cytokine activity, immune/inflammatory response and chemokine activity. All the pathways obtained through KEGG analysis were associated with immune responses. And we also found that cytokine--cytokine receptor interaction, the Toll-like receptor signaling pathway, IL-17 signaling pathway and chemokine signaling pathway were significantly enriched, which was predicted that these signaling pathways might play an important role in future immunotherapy research.

In summary, the CIBERSORT algorithm was used to analyze the LM22 immune cell subsets in GC and provided information about the immune cell landscape of GC. Our findings also revealed the important correlation of clinical outcome with the LM22 immune cell infiltration model in a TME. The present study helped clarify the tumor responses to immunotherapy and might be used as a basis for discovering highly possible targets of new drugs.

Supplementary Material
======================

###### Supplementary Figures S1-S6

###### 

Click here for additional data file.

Data Availability {#sec5}
=================

The data used to perform the analyses described herein are publically available from official TCGA data portal.

Competing Interests {#sec6}
===================

The authors declare that there are no competing interests associated with the manuscript.

Funding {#sec7}
=======

This work was supported by Guizhou Science and Technology Foundation \[grant number \[2020\]1Y427\]; National Natural Science Foundation of China \[grant numbers 81360366, 81302169\]; Guizhou High-level Innovative Talents Foundation \[grant number GZSYQCC\[2014\]001\]; Guizhou Outstanding Young Scientific and Technological Talents Foundation \[grant number \[2017\]5602\]; Guizhou Innovation and Entrepreneurship Foundation for High-level Overseas Talent \[grant number \[2018\]04\]; Guizhou Science and Technology Foundation \[grant numbers \[2019\]1198, \[2020\]1Z064\].

Author Contribution {#sec8}
===================

M.W., J.S., J.D. and Y.W. wrote the main manuscript text. M.W. and H.L. prepared the figures and tables. M.W. and Y.W. contributed to data analysis. All authors reviewed the manuscript.

Ethics Approval {#sec9}
===============

There is no need for ethical approval from the hospital since all the data in the manuscript were based upon bioinformatics and that the TCGA obtained informed consent from all participants.

AUC

:   area under the curve

CDF

:   cumulative distribution function

CIBERSORT

:   Cell type Identification By Estimating Relative Subsets Of known RNA Transcripts

DEG

:   differentially expressed gene

FDR

:   false discovery rate

GC

:   gastric cancer

GO

:   Gene Ontology

GSVA

:   gene set variation analysis

IL

:   interleukin

KEGG

:   Kyoto Encyclopedia of Genes and Genomes

KRAS

:   Kirsten rat sarcoma viral oncogene homolog

OS

:   overall survival

TCGA

:   The Cancer Genome Atlas

TIIC

:   tumor-infiltrating immune cell

TMAO

:   trimethylamine-N-oxide

TME

:   tumor microenvironment

TNM

:   tumor node metastasis

Treg

:   regulatory T cell
